Literature DB >> 31388270

Establishing Blood Group Genotyping to Resolve ABO Discrepancies in Iran.

M Khorshidfar1, A Chegini1, A A Pourfathollah1, A Oodi1, N Amirizadeh1.   

Abstract

ABO discrepancies are recognized when the reactions obtained in the forward type do not "match" the reactions obtained in the reverse type. Discrepant results are often caused by a variant ABO gene. Molecular analysis is required to confirm the type of subgroups and discrepancy. In this study ABO genotyping was performed on a series of blood donors and patients to determine their definite blood groups. We examined 100 samples with ABO discrepancies from blood donors and patients referred to Tehran Blood Transfusion Center between October 2015 and August 2016. ABO genotyping was performed on all samples with allele specific PCR for differentiation of A, B and O alleles. Exon 6 and 7 of ABO gene were sequenced to confirm the results. The genotyping of donor/patients samples with discrepant results of ABO blood typing consisted of 61 cases of A2 and A2B, 3 cases of B 302 and 4 cases of Aw06. Genotyping of 6 samples that had extra antibody in their serum (AB blood group) confirmed the cell type reaction results. 6 samples that had shown a very weak reaction with anti-AB (similar to O blood group) and had no anti-A in their serum were genotyped as O 1 O 2. Blood group genotyping laboratory provides an efficient service for evaluation of ABO discrepancies and resolve the problems encountered in serology reactions.

Entities:  

Keywords:  ABO discrepancy; Blood group; Genotyping

Year:  2018        PMID: 31388270      PMCID: PMC6646629          DOI: 10.1007/s12288-018-1044-8

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  23 in total

1.  Molecular heterogeneity of the A3 subgroup.

Authors:  M L Barjas-Castro; M H Carvalho; M F Locatelli; S Bordin; S T Saad
Journal:  Clin Lab Haematol       Date:  2000-04

2.  Genomic analysis of clinical samples with serologic ABO blood grouping discrepancies: identification of 15 novel A and B subgroup alleles.

Authors:  M L Olsson; N M Irshaid; B Hosseini-Maaf; A Hellberg ; M K Moulds; H Sareneva; M A Chester
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

3.  Allelic genes of blood group antigens: a source of human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation Database.

Authors:  Olga O Blumenfeld; Santosh K Patnaik
Journal:  Hum Mutat       Date:  2004-01       Impact factor: 4.878

4.  Structural basis for red cell phenotypic changes in newly identified, naturally occurring subgroup mutants of the human blood group B glycosyltransferase.

Authors:  Bahram Hosseini-Maaf; James A Letts; Mattias Persson; Elizabeth Smart; Pierre-Yves LePennec; Hein Hustinx; Zhihon Zhao; Monica M Palcic; Stephen V Evans; M Alan Chester; Martin L Olsson
Journal:  Transfusion       Date:  2007-05       Impact factor: 3.157

Review 5.  Sequence variation at the human ABO locus.

Authors:  S P Yip
Journal:  Ann Hum Genet       Date:  2002-01       Impact factor: 1.670

6.  A weak blood group A phenotype caused by a new mutation at the ABO locus.

Authors:  Axel Seltsam; Michael Hallensleben; Britta Eiz-Vesper; Volker Lenhard; Giudo Heymann; Rainer Blasczyk
Journal:  Transfusion       Date:  2002-03       Impact factor: 3.157

7.  New and unusual O alleles at the ABO locus are implicated in unexpected blood group phenotypes.

Authors:  Bahram Hosseini-Maaf; Nidal M Irshaid; Asa Hellberg; Thomas Wagner; Cyril Levene; Hein Hustinx; Rudi Steffensen; M Alan Chester; Martin L Olsson
Journal:  Transfusion       Date:  2005-01       Impact factor: 3.157

8.  An extensive polymerase chain reaction-allele-specific polymorphism strategy for clinical ABO blood group genotyping that avoids potential errors caused by null, subgroup, and hybrid alleles.

Authors:  Bahram Hosseini-Maaf; Asa Hellberg; M Alan Chester; Martin L Olsson
Journal:  Transfusion       Date:  2007-11       Impact factor: 3.157

9.  An international study of the performance of sample collection from patients.

Authors:  W H Dzik; M F Murphy; G Andreu; N Heddle; C Hogman; R Kekomaki; S Murphy; M Shimizu; C T Smit-Sibinga
Journal:  Vox Sang       Date:  2003-07       Impact factor: 2.144

10.  The nature of diversity and diversification at the ABO locus.

Authors:  Axel Seltsam; Michael Hallensleben; Anke Kollmann; Rainer Blasczyk
Journal:  Blood       Date:  2003-06-26       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.